Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to...
Transcript of Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to...
![Page 1: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/1.jpg)
CCEB
Introduction toPharmacoepidemiology Methods
• Background re: Epi Methods• Present• Future
![Page 2: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/2.jpg)
CCEB
Options in Research Design
• Analytic Studies–Experimental Study–Cohort Study–Case-Control Study
• Descriptive Studies–Analyses of Secular Trends–Case Series–Case Reports
![Page 3: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/3.jpg)
CaseCase--Control StudiesControl Studies
DiseaseDisease
Coh
ort S
tudi
esC
ohor
t Stu
dies
Fact
orFa
ctor
PresentPresent(cases)(cases)
AbsentAbsent(not (not exposed)exposed)
PresentPresent(exposed)(exposed)
AbsentAbsent(controls)(controls)
AA
DDCC
BB
![Page 4: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/4.jpg)
CCEB
Prospective vs. Retrospective Studies
EventsUnder Study
Prospective Study
Time
Retrospective Study
![Page 5: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/5.jpg)
CCEB
Pharmacoepidemiology:Unique Characteristics
1. A large population needs to be studied
2. Randomized clinical trials are unlikely to be productive
3. Answers often must be obtained very quickly
![Page 6: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/6.jpg)
CCEB
![Page 7: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/7.jpg)
Hypothesis Generating
Hypothesis Strengthening
Hypothesis Testing
CCEB
![Page 8: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/8.jpg)
Current Status of Pharmacoepidemiology
CCEB
![Page 9: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/9.jpg)
CCEB
Data Sources for PharmacoepidemiologyStudies
• Spontaneous case reports of adverse reactions
• Aggregate population-based data sources
• Computerized collections of data from organized medical care programs
• Data collected for pharmacoepi on an ongoing basis
• Existing data collected as part of other ad hoc studies
• Data collected de novo
![Page 10: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/10.jpg)
CCEB
Spontaneous Reports of AdverseReactions: Advantages
• Incorporates all drugs• Incorporates all prescribers• Relatively inexpensive
![Page 11: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/11.jpg)
CCEB
Spontaneous Reports of AdverseReactions: Disadvantages
• Under- or over-ascertainment• Under-reporting• External events can change
ascertainment or reporting• No denominators
![Page 12: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/12.jpg)
CCEB
Using Vital Statistics and Sales Datato Perform Analyses of Secular Trends
• Advantages: Fast and relatively inexpensive
• Disadvantages: -Cannot differentiate among alternative exposures with consistent trends-Findings can be artifactual
![Page 13: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/13.jpg)
CCEB
Computerized Collections of Billing Data:Sources of Data
Provider: Hospital Payor
Provider: Physician
Provider: Pharmacy
DataUser
![Page 14: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/14.jpg)
CCEB
Computerized Collections of MedicalBilling Data: Advantages
• Size• Cost• Complete• Can be population-based• Can include outpatient drugs and diseases
• No recall or interviewer bias
![Page 15: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/15.jpg)
CCEB
Computerized Collections of MedicalBilling Data: Disadvantages
• Uncertain validity of diagnosis data• No information on some potential
confounding variables• Only includes illnesses severe
enough to come to medical attention• Some results may not be
generalizable, e.g., on health care utilization
![Page 16: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/16.jpg)
CCEB
Medical Records Databases(e.g., GPRD, THIN)
Advantages Disadvantages• Completeness of data • GP data only• Quality of data • Completeness of
outcomes uncertain• Easy access to primary • May be a skewed
medical records group of docs
![Page 17: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/17.jpg)
CCEB
Data Collected for PMS on an Ongoing Basis: BCDSP Hospital-Based
SurveillanceAdvantages Disadvantages
• Denominator known • Inpatient drugs only• Quality of data • Short-term effect
only• Common effects only• Old: data cannot be
used to study new drugs
![Page 18: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/18.jpg)
CCEB
Data Collected for PMS on an OngoingBasis:Drug (Slone) Epidemiology Unit
Advantages Disadvantages• Study of rare illnesses • Hospitalized dzs only• Quality of data • Denominator
unknown• ?Validity of rx data• Cannot be used to
study new drugs
![Page 19: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/19.jpg)
CCEB
Existing Data Collected as Part of Other Ad Hoc Studies
• Advantages: Cost, speed• Disadvantages: Incomplete
data, lack of quality control
![Page 20: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/20.jpg)
CCEB
Data Collected De Novo Forthe Study Being Conducted
• Advantage: Completely tailored data
• Disadvantages: Cost, time delay
![Page 21: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/21.jpg)
CCEB
Prescription Event Monitoring
Advantages Disadvantages• Large population • Participation rate• Quality of data • Cost
• Time delay• Limited numbers of
drugs
![Page 22: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/22.jpg)
Future of Pharmacoepidemiology
CCEB
![Page 23: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/23.jpg)
CCEB
Future Scientific Developments
• Applications of new epi methods• Drug utilization review programs• Evaluation of causality in case reports• Systematic screening for ADRs• Appropriate role of data mining• Studies of beneficial drug effects• Studies of pharmacoeconomics• Studies to aid in individualizing drug
therapy• Quality of life studies• Large simple trials
![Page 24: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/24.jpg)
CCEB
Future Logistic Approaches
• More data bases• US Medicare• Pharmacy-based
surveillance• Poison control centers• Others?
![Page 25: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/25.jpg)
CCEB
Molecular Pharmacoepidemiology
• Use of molecular methods to measure genetics in traditional case-control studies
• Use of molecular methods to measure individuals’ probability of drug response
![Page 26: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/26.jpg)
CCEB
New Structures Which Will be Affectingthe Future of Pharmacoepidemiology
• Hospital initiatives• CERTs• Patient Safety Initiatives• CPOE• HIPAA• Risk management• Medicare Part D• IOM!?!?
![Page 27: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/27.jpg)
CCEB
Key Problem of “Historical”Pharmacoepidemiology
• Adverse drug events are the most common iatrogenic causes of patient injuries
• Most are the result of an exaggerated but otherwise usual pharmacological effect of the drug
• Yet, historically these have been ignored by pharmacoepidemiology, as they do not represent a focus of commercial and regulatory interest
![Page 28: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/28.jpg)
CCEB
Potential Threats to the Continued Development of Pharmacoepidemiology
• Scientific errors• Funding limitations• Absence of training programs• Corruption by studies
conducted purely for marketing purposes
• Inappropriate use in litigation
![Page 29: Introduction to Pharmacoepidemiology Methods/media/Files/Activity Files/Quality...Introduction to Pharmacoepidemiology Methods ... •Studies of pharmacoeconomics ... Strom 1-12-06.ppt](https://reader031.fdocuments.in/reader031/viewer/2022021421/5aaab43b7f8b9a9a188e903e/html5/thumbnails/29.jpg)